Delivery Order SPE2DB20D3103-SPE2DB25FP9D9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,371.94 firm-fixed-price delivery order is for the supply of 4,561,154,848 units of Escitalopram 20 mg tablets. The contract has an ultimate completion date of June 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of 4,558,338,870 tablets of the prescription drug escitalopram 20 mg to the Defense Logistics Agency (DLA). The $27,595.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 6, 2022 with a completion date of September 7, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,969,471 tablets of escitalopram 20 mg. The $1,331.21 contract has a period of performance through March 15, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to support DLA Troop Support Medical facilities and military treatment programs. The contract is not...
- Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,835,906 units of escitalopram 20 mg tablets. The $1,162.59 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) it holds with DLA, valued at up to...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4,566,307,044 units of the drug Escitalopram 10 mg tablet. The $1,409.47 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. The contract has an ultimate completion date of November 4, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, valued at $3,558.49 under a firm fixed-price contract. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The pharmaceutical product is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,000 tablets of the medication escitalopram 10 mg. The $5,172.54 contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Escitalopram 5 mg tablets. The award, valued at $10,032.42, is a Firm Fixed Price Delivery Order contract with a completion date of September 26, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,761.77 to Amerisourcebergen Drug Corp, a for-profit corporation based in Conshohocken, Pennsylvania. The contract is for the supply of 1,000 units of the prescription medication Escitalopram 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,250 units of the pharmaceutical drug Escitalopram 10 mg tablets. The $1,757.34 contract has a performance period ending on January 8, 2024 and will be executed from Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp has a long history of providing pharmaceutical products and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9D9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (90-count units) under a firm fixed-price contract valued at $1,156.44. The award was made on August 15, 2025, with an ultimate completion date of August 18, 2025, and does not include a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide, enabling the company to distribute a broad range of generic and brand-name medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's position as a major pharmaceutical distributor with extensive federal contracting experience demonstrates its capability to fulfill critical medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/15/25 |